UPMC Procirca Adult ECMO Training Course Spring 2024

Pittsburgh, PA US
April 24, 2024 to April 26, 2024

UPMC Procirca is excited to announce our newly ELSO-endorsed Adult ECMO Training Course that meets step 1 and step 2 requirements for the ELSO Adult ECMO certification Exam (E-AEC). The course will be held in person at The Oaklander Hotel in Pittsburgh on April 24 to 26, 2024. Didactic sessions, lead by clinical domain experts from critical care medicine, cardiothoracic surgery, and perfusion services, along with high-fidelity, immersive simulations allows UPMC Procirca to provide a truly comprehensive educational experience for providers of all backgrounds and disciplines. 

Target Audience

This 3-day course is designed for the bedside ECMO caregiver including physicians, physician assistants, perfusionists, nurses, nurse practitioners, ECMO specialists, and respiratory therapists.

Additional Information

Course summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 0.25 Attendance
Course opens: 
01/09/2024
Course expires: 
12/31/2024
Event starts: 
04/24/2024 - 8:00am EDT
Event ends: 
04/26/2024 - 5:00pm EDT
Cost:
$1.00

UPMC PROCIRCA ADULT ECMO TRAINING COURSE

WEDNESDAY, APRIL 24

0700-0730            BREAKFAST/REGISTRATION

0730-0800            ECMO OVERVIEW                                                                          
KERI HICKMAN, CCP

  • ECMO OVERVIEW
    • Different modes of ECMO support
    • Global trends in ECMO utilization

0800-0830            PAST TO PRESENT: HISTORY & RECENT EVIDENCE
HOLT MURRAY, MD

  • HISTORY OF ECMO
    • List the key milestones in the development of ECMO
    • Describe the evolution of the Extracorporeal Life Support Organization
  • HISTORICAL STUDIES
    • List the historical ECMO studies and their limitations
  • RECENT EVIDENCE FOR VV ECMO
    • Interpret results and limitations of the main cohort studies on VV ECMO
    • Interpret results and limitations of the CESAR and the EOLIA trials
  • RECENT EVIDENCE FOR VA ECMO
    • Interpret results and limitations of the main cohort studies on VA ECMO
    • Interpret results of studies/trials comparing temporary VADs to VA ECMO

0830-0900            CIRCUIT COMPONENTS
BRANDON D’ALOISO, CCP

  • CIRCUIT OVERVIEW
    • Define the main components of an ECMO circuit
    • List circuit monitoring tools
  • CANNULAS & TUBING
    • Describe the differences in ECMO cannula design
    • List the considerations for selecting the appropriate ECMO cannula
  • PUMP
    • Describe the requirements of a blood pump used in ECMO
    • Explain the physics and working principles of a centrifugal pump
  • MEMBRANE LUNG & BLENDER
    • Describe the structure and function of the membrane lung
    • Describe the function of the blender
  • PRESSURE MONITORING
    • List the different pressure zones in an ECMO circuit
    • Discuss the utility of monitoring drainage pressure
  • OTHER CIRCUIT COMPONENTS
    • Describe the utility of the flowmeter
    • Describe the function of the heater
    • Describe the utility of circuit clamps

0900-0930            CONFIGURATIONS & CANNULATIONS
RAJ RAMANAN, MD

  • CANNULATION
    • List the differences between percutaneous and open cannulation
    • Outline the process of percutaneous cannulation
    • Discuss the role of ultrasound in cannulation
  • VV ECMO CONFIGURATIONS
    • List the different configurational options for VV ECMO
    • Review the benefits and limitations of specific configurations
  • VA ECMO CONFIGURATIONS
    • List the different configurational options for VA ECMO
    • Review benefits and limitations of specific configurations
  • CANNULATION COMPLICATIONS
    • Identify complications of ECMO cannulation
    • Describe steps to prevent, recognize, and treat complications

0930-0945            BREAK

0945-1030            ECMO PHYSIOLOGY
RAJ RAMANAN, MD

  • OXYGEN DELIVERY & UPTAKE
    • Describe the normal physiology of oxygen delivery and uptake
  • GAS TRANSFER IN MEMBRANE LUNG
    • Describe the key determinants of oxygen uptake in the membrane lung
    • Describe the key determinants of carbon dioxide removal in the membrane lung
  • HEMODYNAMIC MONITORING OF VV
    • List the hemodynamic changes that accompany VV ECMO
    • Describe the changes in hemodynamic monitoring on VV ECMO
  • HEMODYNAMIC MONITORING OF VA
    • Discuss the hemodynamic changes that accompany VA ECMO
    • Describe the changes in hemodynamic monitoring on VA ECMO

1030-1100            INTERHOSPITAL TRANSPORT
FRANK GUYETTE, MD

  • INTERHOSPITAL TRANSPORT
    • Identify considerations and logistics for interhospital transport

1100-1130            DAILY MANAGEMENT FOR THE ECMO SPECIALIST
KERI HICKMAN, CCP

  • RENAL REPLACEMENT THERAPY
    • Identify the benefits and limitations of administering RRT via a dialysis catheter
    • Identify the benefits and limitations of administering RRT via the ECMO circuit
  • INTRAHOSPITAL TRANSPORT
    • Identify considerations and logistics for intrahospital transport

1130-1230            LUNCH

1230-1300            DAILY MANAGEMENT FOR THE ECMO PROVIDER
TIM KASELITZ, MD

  • SEDATION
    • Identify the role of sedation during ECMO support
    • Discuss the paradigm shift towards awake ECMO
  • PROCEDURES
    • Discuss considerations for procedures on the ECMO patient
  • PHYSIOTHERAPY
    • Describe the rationale for physiotherapy during ECMO
    • Identify appropriate candidates for physiotherapy on ECMO

1300-115              INTRODUCTION TO SIMULATION
KERI HICKMAN, CCP

1315-1345            CIRCUIT GAME

1345-1515            CENTRIMAG KNOBOLOGY, PRIMING, CONSOLE EXCHANGE, AIR REMOVAL TECHNIQUES,                 CIRCUIT CHECK

1515-1530            BREAK

1530-1700            CARDIOHELP KNOBOLOGY, PRIMING, HAND CRANKING, AIR REMOVAL TECHNIQUES,                       CIRCUIT CHECK

SIMULATION FACULTY: RAJ RAMANAN, MD; TIM KASELITZ, MD; VERONICA GARVIA, MD; KERI HICKMAN, CCP; BRANDON D’ALOISO, CCP; TYLER EADIE, CCP; AMBER PALMER,CCP

1700                      Day 1 Adjournment

THURSDAY, APRIL 25

0700-0730            BREAKFAST/SIGN IN

0730-0800            RESPIRATORY FAILURE
TIM KASELITZ, MD

  • Provide an overview of respiratory failure
  • List standard management strategies for respiratory failure
  • Discuss the rationale of VV ECMO in respiratory failure

0800-0830            PATIENT SELECTION FOR VV ECMO
RAJ RAMANAN, MD

  • List the indications and contraindications for VV ECMO support

0830-0900            MANAGEMENT OF VV ECMO
RAJ RAMANAN, MD

  • INTIATION OF VV ECMO
    • Describe the steps in initiating a patient onto VV ECMO
  • VV ECMO MAINTENANCE
    • Describe titration of blood flow and gas flow to achieve adequate support on VV ECMO
    • Describe the concept of native lung rest
  • WEANING VV ECMO
    • Describe the process of weaning VV ECMO support
    • List exit strategies for the VV ECMO patient

0900-0930            EXHIBITOR BREAK

0930-1000            VV ECMO CASE VIGNETTES
RAJ RAMANAN, MD

  • DRAINAGE INSUFFIENCY
    • Define and diagnose drainage insufficiency
    • Troubleshoot drainage insufficiency
  • RETURN OBSTRUCTION
    • Define return obstruction and identify its causes
    • Diagnose and manage return obstruction
  • RECIRCULATION
    • Define and identify recirculation
    • Troubleshoot recirculation

1000-1030            CIRCUIT COMPLICATIONS
PETER ARLIA, CCP

  • (MECHANICAL) COMPLICATIONS OVERVIEW
  • PUMP FAILURE
    • Define pump failure
    • Describe how to identify and manage pump failure
  • MEMBRANE LUNG DYSFUNCTION
    • Define membrane lung dysfunction
    • Describe how to diagnose and manage membrane lung dysfunction
  • AIR EMBOLISM
    • Define air embolism and its determinants
    • Define strategies to prevent air embolism
    • Describe how to detect and manage air embolism
  • CIRCUIT DISRUPTION
    • Identify determinants of circuit disruption
    • Recognize early signs of circuit disruption
    • Manage circuit disruption
  • ACCIDENTAL DECANNULATION
    • Manage an accidental decannulation
  • COMING OFF ECMO EMERGENTLY
    • List the indications for coming off ECMO emergently
    • List the steps required to come off and back on ECMO emergently

1030-1100            PATIENT COMPLICATIONS
VERONICA GARVIA, MD

  • (MEDICAL) COMPLICATIONS OVERVIEW
  • NEUROLOGICAL COMPLICATIONS
    • List the etiology and risk factors for neurological complications
    • Discuss the management of ischemic and hemorrhagic strokes
  • BLEEDING
    • List the etiology of bleeding
    • Discuss the management of bleeding
  • THROMBOSIS
    • List the etiology of thrombosis
    • Discuss the management of thrombosis
  • HEMOLYSIS
    • Understand the etiology and risk factors of hemolysis on ECMO
    • Discuss how to prevent and manage hemolysis
  • LIMB ISCHEMIA
    • List the risk factors for developing limb ischemia on VA ECMO
    • Describe how to monitor limb perfusion
    • Discuss the prevention and management of limb ischemia
  • CARDIAC ARREST DURING ECMO
    • Discuss the management of cardiac arrest on VV ECMO
    • Discuss the management of cardiac arrest on VA ECMO

1100-1130            CODING & BILLING FOR THE ECMO PROVIDER
TBD

    • Describe rationale for accurate documentation
    • Describe process of coding & billing
    • Quality assurance

1130-1230            EXHIBITOR LUNCH

1230-1245            INTRODUCTION TO SIMULATION
KERI HICKMAN, CCP

1245-1645            VV SIMULATION

SIM 1: RECRICULATION

SIM 2: DRAINAGE INSUFFICIENCY

SIM 3: MEMBRANE LUNG FAILURE

SIM 4: AIR EMBOLISM

SIMULATION FACULTY: RAJ RAMANAN, MD; TIM KASELITZ, MD; VERONICA GARVIA, MD;  PETER ARLIA, CCP; KERI HICKMAN, CCP; BRANDON D’ALOISO, CCP; TYLER EADIE, CCP; AMBER PALMER,CCP; ALYSSA MCCUNE, CCP

1700                      Day 2 Adjournment

1700-1900            EXHIBITOR MEET & GREET

FRIDAY, APRIL 26

0700-0730            BREAKFAST/SIGN IN

0730-0800            CARDIAC FAILURE
DAVID KACZOROWSKI, MD

  • Provide an overview of cardiac failure
  • List standard management strategies for cardiac failure
  • Discuss the rationale of VA ECMO in cardiac failure

0800-0830            PATIENT SELECTION FOR VA ECMO
MICHAEL LAZAR, MD

  • List the indications and contraindications for VA ECMO support

0830-0900            MANAGEMENT OF VA ECMO
DAVID KACZOROWSKI, MD

  • INITIATION OF VA ECMO
    • Describe the steps for initiating a patient
  • VA MAINTENANCE
    • Describe vasopressor use and blood flow titration for cardiovascular support
    • Describe the concept of native heart rest
    • Describe ventilator management and blood and gas flow titration for pulmonary support
  • WEANING VA ECMO      
    • Describe the process of weaning VA ECMO support
    • List exit strategies for the VA ECMO patient

0900-0930            VA ECMO CASE VIGNETTES
RAJ RAMANAN, MD

  • LV DISTENTION
    • Describe the mechanism of LV distention
    • List strategies to unload the left ventricle
  • DIFFERENTIAL OXYGENATION
    • Define and identify differential oxygenation
    • Troubleshoot differential oxygenation

0930-0945            BREAK

0945-1015            ECPR
DAVID KACZOROWSKI, MD

  • Describe ECPR
  • Interpret results and limitations of the major clinical trials on ECPR
  • Patient selection with emphasis on inclusion and exclusion criteria
  • Logistics of establishing and maintaining an ECPR program

1015-1045            ANTICOAGULATION
RYAN RIVOSECCHI, PHARMD

  • ANTICOAGULATION
    • List anticoagulation strategies on ECMO
    • Discuss anticoagulation monitoring on ECMO

1045-1100            INTRODUCTION TO SIMULATION
KERI HICKMAN, CCP

1100-1200            LUNCH

1200-1600            VA SIMULATION

SIM 1: LV DISTENTION

SIM 2: PUMP FAILURE

SIM 3: GAS FAILURE

SIM 4: DIFFERENTIAL OXYGENATION WITH HYPOXEMIA

SIMULATION FACULTY: RAJ RAMANAN, MD; TIM KASELITZ, MD; VERONICA GARVIA, MD;  PETER ARLIA, CCP; KERI HICKMAN, CCP; BRANDON D’ALOISO, CCP; TYLER EADIE, CCP; AMBER PALMER,CCP; ALYSSA MCCUNE, CCP

1600-1630            Q&A WITH FACULTY

RAJ RAMANAN, MD; TIM KASELITZ, MD; VERONICA GARVIA, MD; PETE ARLIA, CCP; KERI HICKMAN, CCP

1630                       COURSE ADJOURNMENT

The Oaklander Hotel
5130 Bigelow Boulevard
Pittsburgh, PA 15213
United States

Room block rate: $269/night

Contact Keri Hickman to reserve a room. Cutoff date to reserve through the hotel room block is 3/21/24. 

Course Directors 
Raj Ramanan, MD
Assistant Professor of Critical Care Medicine
Department of Critical Care Medicine
Medical Director, ECMO
Director, Procirca ECMO Education 
University of Pittsburgh Medical Center
Pittsburgh, PA


David Kaczorowski, MD
Associate Professor of Cardiothoracic Surgery 
Surgical Director, Advanced Heart Failure Center
Department of Cardiothoracic Surgery
University of Pittsburgh School of Medicine
Pittsburgh, PA


Michael Lazar, MD, MHA, FACC
Executive Medical Director, UPMC Williamsport HVI
Regional Director, HVI Cardiac Surgery UPMC Williamsport, Altoona, and Western Maryland 
University of Pittsburgh Medical Center 
Williamsport, PA

This activity is approved for the following credit: AMA PRA Category 1 Credit™. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. 
 

Available Credit

  • 0.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 0.25 Attendance

Price

Cost:
$1.00
Please login or register to take this course.

Cost: $3,000 (includes the ELSO Red Book)

**No discounted rate for UPMC employees

Questions? Contact procircaecmo@procirca.com

Cancellation/refund statement: All cancellations must be sent via email, nealka3@upmc.edu. Cancellations received before 3/24/24 will be refunded in full. After 3/24/24, a $1,000 fee will be assessed, and no refunds will be made after 4/21/24.